(Q44615998)

4 December 2017

0 references

Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials (English)

1 reference

coronary balloon angioplasty

4 December 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556866

Cardiology and cardiovascular medicine

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00970-6

20 March 2024

9

A Michael Lincoff

1 reference

4 December 2017

2

Deepak L Bhatt

1 reference

4 December 2017

1

Derek P. Chew

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556866

20 March 2024

author name string

William Kimball

3

1 reference

4 December 2017

Peter Berger

5

1 reference

4 December 2017

Frederick Feit

7

1 reference

4 December 2017

Timothy D. Henry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556866

20 March 2024

Peter A. McCullough

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556866

20 March 2024

John A. Bittl

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556866

20 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14556866

full work available at URL

20 March 2024

https://api.elsevier.com/content/article/PII:S0002914903009706?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00970-6

https://api.elsevier.com/content/article/PII:S0002914903009706?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00970-6

American Journal of Cardiology

20 March 2024

published in

1 reference

4 December 2017

volume

92

1 reference

4 December 2017

issue

8

1 reference

4 December 2017

page(s)

919-923

1 reference

The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Renal implications of percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Clinical outcomes of bivalirudin for ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Cardiovascular outcomes and renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Risks associated with renal dysfunction in patients in the coronary care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Premature cardiovascular disease in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

C reactive protein in patients with chronic renal diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Bleeding and thrombosis in chronic uremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Bleeding in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Increased thrombin generation in patients with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900970-6

Acquired antithrombin III deficiency in patients with glomerular proteinuria

7 January 2021

27

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(03)00970-6

20 March 2024

Identifiers

1 reference

4 December 2017

1 reference